BioSpace News Archive

Press Releases

Cytokinetics Announces Start of COMET-HF, a Confirmatory Phase 3 Clinical Trial of Omecamtiv Mecarbil in Patients with Symptomatic Heart Failure with Severely Reduced Ejection Fraction

December 4, 2024
·
12 min read
Press Releases

Priothera to Present Trial in Progress Poster for Mocravimod at 2024 American Society of Hematology (ASH) Annual Meeting

December 4, 2024
·
3 min read
Press Releases

Spur Therapeutics Announces Development Candidate in Parkinson’s Disease Gene Therapy Program

December 4, 2024
·
5 min read
Press Releases

Kraig Biocraft Laboratories Announces Investor Web Conference Highlighting Commercialization Progress of Spider Silk Technologies

December 4, 2024
·
2 min read
Press Releases

Diagonal Therapeutics to Present Data at ASH 2024 Demonstrating the Economic and Clinical Burden of Hereditary Hemorrhagic Telangiectasia (HHT)

December 4, 2024
·
4 min read
Press Releases

Tonix Pharmaceuticals Announces Expansion of Leadership Team with Two Strategic Hires

December 4, 2024
·
12 min read
Press Releases

Adaptive Biotechnologies Announces Over 65 Abstracts Featuring clonoSEQ® MRD Testing Across a Range of Blood Cancers to be Presented at the 66th ASH Annual Meeting

December 4, 2024
·
5 min read
Press Releases

Pacira Awarded New U.S. Patent Covering EXPAREL Composition

December 4, 2024
·
7 min read
Press Releases

Vasomune and AnGes Announce Drug Candidate AV-001 Receives Positive IDSMB Recommendation to move to the High-Dose Cohort for AV001-004 Phase 2a Study

December 4, 2024
·
3 min read
Press Releases

Neuron23 Announces First-in-human Dose in Phase 1 Clinical Trial of NEU-111, a TYK2 Inhibitor with Best-in-class Potential for Immune-mediated Inflammatory Disorders

December 4, 2024
·
2 min read